Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Not yet recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Thoracic 3Sarcoma 3Head & Neck 3Gastrointestinal 2Dermatologic 2Plasma cell 1Other solid neoplasm 1Gynecologic 1Genitourinary 1Endocrine 1CNS 1Breast 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Mesothelioma, Malignant 1Head and Neck Neoplasms 1Basal Cell Carcinoma of the Head and Neck 1

Interventions

pembrolizumab 180Cisplatin 157Radiotherapy 78Carboplatin 71Radiotherapy, Intensity-Modulated 69Cetuximab 66Magnetic Resonance Spectroscopy 64Nivolumab 63Paclitaxel 52Docetaxel 50Specimen Handling 45Radiation 35Gemcitabine 33Fluorouracil 31Surveys and Questionnaires 28Biopsy 27toripalimab 26Drug Therapy 26Platinum 25Surgical Procedures, Operative 24Standard of Care 231,2-diaminocyclohexaneplatinum II citrate 23cemiplimab 22atezolizumab 21Capecitabine 20Ipilimumab 19Chemoradiotherapy 19durvalumab 18Taxes 17Immune Checkpoint Inhibitors 17

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Tissue Banks × Head & Neck × 1 year × Clear all
NCT07550049 2026-04-24

COMETH

University of Kansas Medical Center

Not yet recruiting
110 enrolled
Head & NeckOther solid neoplasmThoracic

Mesothelioma, Malignant, Head and Neck Neoplasms, Small Cell Lung Carcinoma

NCT04305366 2026-02-24

MicroRNA Markers in Head and Neck Cancers

University of Colorado, Denver

Active not recruiting
225 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT04323202 2025-10-24

Neoadjuvant-Adjuvant Pembrolizumab in Resectable Advanced Basal Cell Carcinoma of H&N

Case Comprehensive Cancer Center

Phase 1 Completed
13 enrolled
DermatologicHead & Neck

Basal Cell Carcinoma of the Head and Neck

Data powered by HemOnc (CC BY 4.0) Colophon âš¡